Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.

Ph-like ALL was found to be characterized by a range of genomic alterations that activate a limited number of signaling pathways, all of which may be amenable to inhibition with approved tyrosine kinase inhibitors.